Association between circulating DNA, serum (1→3)-d-glucan, and pulmonary fungal burden in Pneumocystis pneumonia

Clinical Infectious Diseases

Volumn 55, Issue 2, 2012, Pages

  Costa, Jean Marc ^a,b   Botterel, Françoise ^a   Cabaret, Odile ^a   Foulet, Françoise ^a   Cordonnier, Catherine ^a   Bretagne, Stéphane ^a,c,d  

^a HENRI MONDOR HOSPITAL   (France)

^b LABORATOIRE CERBA   (France)

^c INSTITUT PASTEUR   (France)

^d CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; FUNGAL DNA;

ARTICLE; BLOOD LEVEL; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE ASSOCIATION; HUMAN; IMMUNOCOMPROMISED PATIENT; LUNG LAVAGE; MAJOR CLINICAL STUDY; MICROSCOPY; NONHUMAN; PATHOGEN LOAD; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY;

BETA-GLUCANS; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; COHORT STUDIES; COLONY COUNT, MICROBIAL; DNA, FUNGAL; HUMANS; IMMUNOCOMPROMISED HOST; PNEUMOCYSTIS JIROVECII; PNEUMONIA, PNEUMOCYSTIS; RETROSPECTIVE STUDIES;

EID: 84864142499     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cis412     Document Type: Article

References (12)

1. Calderon EJ, Gutierrez-Rivero S, Durand-Joly I, Dei-Cas E. Pneumocystis infection in humans: diagnosis and treatment. Expert Rev Anti Infect Ther 2010; 8:683-701.
2. Lamoth F, Cruciani M, Mengoli C, et al. Beta-glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the third European Conference on Infections in Leukemia (ECIL-3). Clin Infect Dis 2012; 54:633-43.
3. Sax PE, Komarow L, Finkelman MA, et al. Blood (1→3)-beta-Dglucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia. Clin Infect Dis 2011; 53:197-202.
4. Botterel F, Cabaret O, Foulet F, Cordonnier C, Costa JM, Bretagne S. Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. J Clin Microbiol 2012; 50:227-31.
5. De Pauw B, Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-21.
6. Roux P, Lavrard I, Poirot JL, et al. Usefulness of PCR for detection of Pneumocystis carinii DNA. J Clin Microbiol 1994; 32:2324-6. (Pubitemid 24258495)
7. Rabodonirina M, Cotte L, Boibieux A, et al. Detection of Pneumocystis carinii DNA in blood specimens from human immunodeficiency virus-infected patients by nested PCR. J Clin Microbiol 1999; 37:127-31. (Pubitemid 29004192)
8. Tamburrini E, Mencarini P, Visconti E, et al. Detection of Pneumocystis carinii DNA in blood by PCR is not of value for diagnosis of P. carinii pneumonia. J Clin Microbiol 1996; 34:1586-8. (Pubitemid 26161037)
9. Wagner D, Koniger J, Kern WV, Kern P. Serum PCR of Pneumocystis carinii DNA in immunocompromised patients. Scand J Infect Dis 1997; 29:159-64.
10. Atzori C, Lu JJ, Jiang B, et al. Diagnosis of Pneumocystis carinii pneumonia in AIDS patients by using polymerase chain reactions on serum specimens. J Infect Dis 1995; 172:1623-6.
11. Schluger N, Godwin T, Sepkowitz K, et al. Application of DNA amplification to pneumocystosis: presence of serum Pneumocystis carinii DNA during human and experimentally induced Pneumocystis carinii pneumonia. J Exp Med 1992; 176: 1327-33.
12. de Boer MG, Gelinck LB, van Zelst BD, et al. β-D-glucan and S-adenosylmethionine serum levels for the diagnosis of Pneumocystis pneumonia in HIV-negative patients: a prospective study. J Infect 2011; 62:93-100.